MYRIAD GENETICS, INC. Other than Temporary Impairment Losses, Investments
MYRIAD GENETICS, INC. (MYGN) reported Other than Temporary Impairment Losses, Investments of $0 for the 9-month period ending 2015-03-31, per its 10-Q filed 2015-05-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2015-05-06
- MYRIAD GENETICS, INC. other than temporary impairment losses, investments for the quarter ending 2015-03-31 was $0.00.
- MYRIAD GENETICS, INC. other than temporary impairment losses, investments for the quarter ending 2014-12-31 was $0.00.
- MYRIAD GENETICS, INC. other than temporary impairment losses, investments for the quarter ending 2014-09-30 was $0.00.
- MYRIAD GENETICS, INC. other than temporary impairment losses, investments for the quarter ending 2014-03-31 was $0.00.
| Period end | Other than Temporary Impairment Losses, Investments 3 month | Other than Temporary Impairment Losses, Investments 6 month | Other than Temporary Impairment Losses, Investments 9 month |
|---|---|---|---|
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $0.00 derived: sum of 2 quarters · filed 2015-05-06 | $0.00 10-Q · filed 2015-05-06 |
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-04 | $0.00 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-05 | ||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-07 | $0.00 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |